Literature DB >> 851795

Guanidine treatment and impaired renal function in the Eaton-Lambert syndrome.

L D Blumhardt, A M Joekes, J Marshall, P E Philalithis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 851795      PMCID： PMC1605790          DOI： 10.1136/bmj.1.6066.946-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors.

Authors:  L M EATON; E H LAMBERT
Journal:  J Am Med Assoc       Date:  1957-03-30

Review 2.  Guanidine derivatives in medicine.

Authors:  F Davidoff
Journal:  N Engl J Med       Date:  1973-07-19       Impact factor: 91.245

3.  Increased paralysis induced by guanidine in motor neuron disease.

Authors:  F H Norris; R J Fallat; P R Calanchini
Journal:  Neurology       Date:  1974-02       Impact factor: 9.910

4.  Guanidine in amyotrophic lateral sclerosis.

Authors:  F H Norris
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245
  4 in total
  3 in total

1.  Elucidating the molecular basis of action of a classic drug: guanidine compounds as inhibitors of voltage-gated potassium channels.

Authors:  Jeet Kalia; Kenton J Swartz
Journal:  Mol Pharmacol       Date:  2011-09-16       Impact factor: 4.436

Review 2.  Treatment for Lambert-Eaton myasthenic syndrome.

Authors:  Michael Keogh; Saam Sedehizadeh; Paul Maddison
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

3.  Lambert-eaton myasthenic syndrome.

Authors:  Maria B Weimer; Joaquin Wong
Journal:  Curr Treat Options Neurol       Date:  2009-03       Impact factor: 3.598
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.